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Computational methods such as 3D-QSAR, docking, vir-
tual screening or structure-based de novo design have
been established over the last years as powerful and fre-
quently consulted tools in lead discovery and develop-
ment. As a matter of fact these methods are approximate,
sometimes due to reasons to keep them computationally
tractable, sometimes simply because we have not yet
understood the involved complexity better, sometimes
because we start from false or inappropriate simplifica-
tions and sometimes because we believe that higher accu-
racy of our considerations is not really required. To move
the quality of our tools forward it is therefore appropriate
to reflect and validate popular assumptions usually
applied in computational approaches. Validation can only
be performed with respect to an agreement with experi-
mental evidence or in some cases highly sophisticated
computational studies that will not be possible on a rou-
tine base.
One popular concept acts on the assumption that a
bound ligand must exhibit perfect shape complementar-
ity with a given binding pocket to achieve high affinity
binding. However, high affinity corresponds to a
strongly negative free energy of binding which can result
from either enthalpic or entropic effects. Thus, also
ligands with high residual mobility and pronounced flex-
ibility can experience strong binding even though their
actual shape complementarity with the binding pocket is
far from perfect.
To keep things simple, additivity of functional group
contributions is a very popular concept in structure-
based drug design. Many scoring functions built on this
assumption, QSAR exploits this idea and medicinal che-
mists love this conception to plan the optimization of
their drug molecules. However, cooperativity of molecu-
lar interactions can easily lead to the breakdown of sim-
ple additivity rules.
It is well known that many of our force-field based
approaches consider better the enthalpic contribution to
binding than the entropic portion. Therefore, one can
frequently find the hypothesis that within a congeneric
series of closely related ligand analogs the entropic con-
tribution to binding is assumed to be equivalent. This
very compliant argument turns out to be a rather arbi-
trary assumption usually not valid even in close conge-
neric series due to enthalpy-entropy compensation
phenomena.
Very pragmatically the protonation states of functional
groups of either residues or candidate ligands are set to
standard values. However, such doing neglects the fact
that strong shifts of pKa values can occur which perturb
the protonation states and even shift ″normal″ into
charge-assisted H-bonds.
Water is an essential partner in ligand binding. Repla-
cement of water from the uncomplexed binding pocket
is assumed to be entropically favorable. However,
depending on the degree of disorder of such water
molecules prior to their replacement the thermodynamic
signature of the water release (hydrophobic effect) can
range from entropic to enthalpic. Furthermore, over
again congeneric ligands can differ in their thermody-
namic signature whether they release or pick-up a cer-
tain number of water molecules upon binding.
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